Tag: Diabetes: Type II
Link Between T2DM, Spinal Degenerative Disorder May Be Method-Dependent
T2DM was an independent risk factor for SDD in logistic regression analysis; no causal relationship seen in MR analyses
Irregular Sleep Duration Tied to Increased Risk for Developing Diabetes
Association was attenuated but still significant after adjustment for lifestyle, comorbidities, environmental factors, adiposity
Aging Into Medicare Tied to Higher Drug Costs for People With Diabetes
Quarterly out-of-pocket costs increased by approximately $23 on average after age 65 years
Suicidal Ideation, Behaviors Not Increased With GLP-1 RAs for Seniors With T2D
No significant increase seen with use of GLP-1 RAs versus SGLT2is or DPP4is among older Medicare beneficiaries
GLP-1 RAs May Reduce Risk for Some Obesity-Linked Cancers Versus Insulin in T2D
Risk reduced for 10 of 13 obesity-associated cancers with GLP-1 RA use versus insulin in individuals with type 2 diabetes
Delaying Diabetes Progression After Impaired Glucose Improves Long-Term Outcomes
Significant risk reduction for death and vascular complications seen with maintaining at least four years of nondiabetes
Few With Type 2 Diabetes Receive Guideline-Recommended CKD Screening
24.9 percent received creatinine and UACR screening; Hispanic ethnicity associated with lack of screening
Dysbiosis in Phylogenetically Diverse Species Associated With Type 2 Diabetes
Within-species phylogenetic diversity identified for strains of 27 species that explain inter-individual differences in type 2 diabetes risk
Timing of Metformin Important in Metformin-Treated Type 2 Diabetes
Glucose lowering is greater when metformin is given before rather than with enteral glucose; this is also linked to greater GLP-1 response
Continuing Metformin in Pregnancy Has Little Effect on Nonlive Birth
Little to no increased risk for nonlive birth seen among women continuing metformin and adding insulin versus switching to insulin monotherapy
